线粒体动力学作为三阴性乳腺癌的新治疗策略
Yuechen Wang1, Narumi Harada-Shoji1, Narufumi Kitamura2
1Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Cancer medicine
|February 9, 2024
概括
线粒体动力学和线粒体有助于三阴性乳腺癌 (TNBC) 中的化疗耐药性. 针对这些独特的线粒体特征可能为TNBC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 三重阴性乳腺癌 (TNBC) 是高度异质的,预后不佳.
- 线粒体动力学在瘤发生过程中至关重要,但它们在TNBC中的作用是复杂的.
- 了解线粒体动力学与TNBC中的代谢类型之间的联系至关重要.
研究的目的:
- 研究线粒体动力学在TNBC耐药性中的作用.
- 探索线粒体动力学与TNBC中的瘤发生之间的关系.
- 在TNBC独特的线粒体代谢中识别潜在的治疗点.
主要方法:
- 使用 Wst-8 测试评估了多克索鲁比辛的敏感性.
- 通过共聚焦显微镜和FACS.量化线粒体膜潜力 (ΔφM),线粒体细胞衰变和反应性氧物种 (ROS).
- 使用Agilent海马XF分析仪分析了代谢特征.
- 在患者样本上对DPR1,帕金和p62进行了免疫组织化学检测.
主要成果:
- TNBC细胞 (MDA-MB-231) 显示出对多克索鲁比辛的敏感性降低,ΔφM降低,以及与氧化酸化 (OXPHOS) 相关的线粒细胞增强.
- 对多克索鲁比敏感细胞 (HCC38) 增加了ROS和糖解,但没有改变ΔφM或线粒细胞衰变.
- 治疗前的DRP1表达在TNBC显著,帕金在荷尔蒙受体阴性BC中显著,低的p62与复发风险相关.
结论:
- 线粒细胞和OXPHOS新陈代谢的相互作用促进TNBC中的化疗耐药性.
- 线粒体裂变是TNBC的一个常见特征.
- 针对TNBC独特的线粒体新陈代谢和动态,提供了一条新的治疗途径.
相关概念视频
Mitochondrial Membranes
10.3K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
10.3K
Electron Transport Chain: Complex I and II
13.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


